Treatments for Blood Clots Caused by Xeljanz
In early 2019, the U.S. Food and Drug Administration (FDA) released the results of an interim analysis on the drug Xeljanz. They began this analysis in 2012 when they first approved Xeljanz for rheumatoid arthritis. In the FDA’s statement, they revealed that they discovered that taking a twice-daily 10mg dose of tofacitinib (the active ingredient in Xeljanz) leads to an increased risk of blood clots and death. In the wake of the FDA’s statement, a host of Xeljanz lawsuits have emerged against Pfizer (the manufacturer of Xeljanz). While the FDA has ceased all 10mg prescriptions of the drug, more and more claims continue to come out. After all, plenty of patients have already experienced these dangerous adverse reactions and want justice. There are two blood clots that the FDA discovered in their analysis: pulmonary embolism and deep vein thrombosis. Both blood clots can be life-threatening… Read More
Class-Action Xeljanz Lawsuits
Ever since the U.S. Food and Drug Administration (FDA) released their findings from an interim analysis of a study on Xeljanz that began in 2012, more and more Xeljanz lawsuits have emerged. These findings revealed that taking a twice-daily 10mg dose of tofacitinib (the active ingredient in Xeljanz) increased your risk of blood clots and death. While all drugs come with inherent risks, you expect the medical benefits to outweigh the potential risks. Often, that is the case. Most drug manufacturers discover a host of side effects before sending their drug to the FDA for approval. Pfizer (the manufacturer of Xeljanz) did report many side effects of Xeljanz. However, an increased risk of blood clots was not one of them. The FDA initially approved Xeljanz for rheumatoid arthritis treatment in 2012, but they did not discover their findings until 2019. In that span, countless individuals… Read More
The Importance of a Dangerous Drug Attorney in a Xeljanz Case
Dangerous Drug Attorneys Have the Skills Necessary to Beat Pharmaceutical Companies When you receive a prescription from your doctor or another authorized healthcare professional, you expect it to help you with whatever condition ails you. While all prescription drugs come with inherent risks, their benefits should outweigh their side effects. Often, that is the case. However, in some instances, people experience adverse reactions that threaten their lives. In 2019, there were over 2,191,808 adverse reactions to prescription drugs in the U.S., according to the U.S. Food and Drug Administration (FDA). Patients need these medications to live comfortably, but they often cause problems far worse than what doctors prescribed them to treat. That is the case for many patients who took Xeljanz. In 2012, the FDA approved Xeljanz for use as a rheumatoid arthritis treatment. Eventually, they also approved the drug for psoriatic arthritis and ulcerative… Read More
Xeljanz and Wrongful Death Cases
Unfortunately, Xeljanz Can Lead to a Wrongful Death Xeljanz is one of the most recent in a long line of prescription medications involved in dangerous drug lawsuits. While the U.S. Food and Drug Administration (FDA) initially approved Xeljanz for rheumatoid arthritis treatment in 2012 (and then again for psoriatic arthritis and ulcerative colitis in 2017 and 2018, respectively), more findings have emerged that warn about the dangers of Xeljanz. In early 2019, the FDA released a Drug Safety Communication statement that announced the findings of an interim analysis of a study they began in 2012. In their statement, the FDA detailed that taking a 10mg dose of tofacitinib (the active ingredient in Xeljanz) twice a day led to an increased risk of blood clots and even death. While Pfizer (Xeljanz’s manufacturer) initially reported several potential side effects, they did not warn anyone about blood clots.… Read More
What Blood Clots Does Xeljanz Cause?
In early 2019, the U.S. Food and Drug Administration (FDA) released a statement warning doctors, patients, and more about new risks associated with Xeljanz. As with any drug, the FDA has to go through a thorough approval process to ensure a drug works the way the manufacturer designed. In their initial tests, they recognized pre-established side effects that the manufacturer (Pfizer) themselves had identified first. However, not everything can be known about a drug in the initial testing. The FDA must conduct longitudinal tests to uncover any other issues, which was the case for Xeljanz. Around the time the FDA initially approved Xeljanz in 2012, they began another study to measure the cardiovascular safety of the drug. The results of their interim analysis of this study in 2019 uncovered that Xeljanz use leads to an increased risk of blood clots and death. Pfizer failed to… Read More
Xeljnaz and Xeljanz XR: What’s the Difference?
In February 2019, the U.S. Food and Drug Administration (FDA) released a Drug Safety Communication statement that announced the discovery of an increased risk of blood clots and death in those taking Xeljanz. Since then, the pharmaceutical company that manufactures Xeljanz (Pfizer) has come under fire. Countless dangerous drug lawsuits have emerged since the release of the FDA’s findings, which have sent Pfizer reeling. Many of these lawsuits claim Pfizer did not design the drug correctly, failed to manufacture it safely, or failed to inform the public of the complete list of dangers. Regardless of if Pfizer was aware of these adverse reactions or not, they still put countless lives at risk. The FDA first approved Xeljanz as a treatment for rheumatoid arthritis in 2012. Since then, thousands of patients have taken the drug. That means that thousands of people are also at risk. Since… Read More
What Damages Can I Recover in My Xeljanz Lawsuit?
The world is full of conditions and diseases that impact millions of people every year. Fortunately, scientists and healthcare experts create prescription drugs that aim to aid those suffering from these conditions. Their purpose is to treat or manage these diseases to ensure that an individual is able to live life well again. However, not all of these medications work the way experts designed them. While the majority of prescription drugs do as they should, many drugs make it into the market that are either designed poorly, manufactured improperly, or marketed incorrectly. These drugs put those taking the prescription at risk of suffering adverse side effects. Xeljanz is one of the most recent in a long line of dangerous drugs. While the U.S. Food and Drug Administration (FDA) initially approved it for rheumatoid arthritis, they eventually approved it for psoriatic arthritis and ulcerative colitis a… Read More
Other Side Effects of Xeljanz That Aren’t Blood Clots
As we have stated numerous times in the past, the U.S. Food and Drug Administration (FDA) must first approve any prescription drug before it hits the market. They follow a thorough process that ensures that the drug works like experts designed it to, and its medical benefits outweigh the inherent risks. After all, while prescription drugs do provide relief and aid in treating many medical conditions, they often come with other side effects. Xeljanz is no different. Since the FDA first approved the drug in 2012, new side effects of the drug have emerged. While the FDA initially discovered a handful of side effects in their initial tests, other adverse reactions came to light in the findings of an interim analysis, which began in 2012. In their results, the FDA discovered that Xeljanz leads to an increased risk of blood clots and death. This recent… Read More
Filing a Xeljanz Lawsuit
As we have spoken about in previous blogs, the U.S. Food and Drug Administration (FDA) approved the prescription drug Xeljanz as a treatment for rheumatoid arthritis in 2012. They eventually approved its use for psoriatic arthritis in 2017 and ulcerative colitis in 2018. However, in the years since its release, cases of Xeljanz leading to adverse reactions have popped up around the country. For some patients taking the drug, they experienced dangerous, potentially life-threatening reactions, such as blood clots. These reactions were not advertised by prescribing doctors nor on the label. In 2019, the FDA released a safety announcement detailing findings they uncovered during an interim analysis of a study conducted in 2012. The study discovered that patients taking a 10mg dose of tofacitinib (the active ingredient in Xeljanz) twice a day had an increased risk of blood clots and death. Since this discovery, the… Read More
What is Xeljanz’s Effect on Your Body?
Whenever scientists and healthcare experts design a new prescription drug, they do so with the intent to help those suffering from an illness or another debilitating condition. More often than not, they do just that. While all prescription drugs come with inherent risks, for the U.S. Food and Drug Administration (FDA) to approve them, they must determine that their health benefits outweigh their risk. Unfortunately, there are instances when unforeseen side effects occur that lead to serious injury or even death. Such is the case with Xeljanz. The FDA first approved Xeljanz as a treatment for rheumatoid arthritis in moderate to severe cases in 2012. They eventually approved its use for psoriatic arthritis in 2017 and ulcerative colitis in 2018. However, in the time since its approval, more and more cases of this drug causing adverse side effects in patients have come to light, leading… Read More